Gene: PLCE1
Official Full Name: phospholipase C epsilon 1provided by HGNC
Gene Summary: This gene encodes a phospholipase enzyme that catalyzes the hydrolysis of phosphatidylinositol-4,5-bisphosphate to generate two second messengers: inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). These second messengers subsequently regulate various processes affecting cell growth, differentiation, and gene expression. This enzyme is regulated by small monomeric GTPases of the Ras and Rho families and by heterotrimeric G proteins. In addition to its phospholipase C catalytic activity, this enzyme has an N-terminal domain with guanine nucleotide exchange (GEF) activity. Mutations in this gene cause early-onset nephrotic syndrome; characterized by proteinuria, edema, and diffuse mesangial sclerosis or focal and segmental glomerulosclerosis. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Sep 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08853 | PLCE1 Knockout cell line (HeLa) | Human | PLCE1 | 1:3~1:6 | Negative | Online Inquiry |
KO08854 | PLCE1 Knockout cell line (HCT 116) | Human | PLCE1 | 1:2~1:4 | Negative | Online Inquiry |
KO08855 | PLCE1 Knockout cell line (HEK293) | Human | PLCE1 | 1:3~1:6 | Negative | Online Inquiry |
KO08856 | PLCE1 Knockout cell line (A549) | Human | PLCE1 | 1:3~1:4 | Negative | Online Inquiry |
PLCE1 Gene Knockout Cell Lines are specialized cell lines developed to silence the PLCE1 gene, which encodes for the enzyme phospholipase C epsilon 1, a pivotal player in various cellular signaling pathways. These knockout cell lines enable researchers to investigate the downstream effects of PLCE1 deficiency, providing a robust platform to study its role in cell growth, differentiation, and apoptosis. By observing how cellular processes are altered in the absence of this enzyme, scientists gain deeper insights into its contribution to pathological conditions, including cancer and cardiovascular diseases.
Mechanistically, the PLCE1 Gene Knockout Cell Lines function by employing CRISPR-Cas9 gene editing technology to create precise deletions in the PLCE1 gene. This ensures a complete abrogation of its expression, thus allowing for the evaluation of the resulting phenotypic changes. Importantly, the absence of PLCE1 has been linked to various signaling cascades such as those related to the regulation of ion channels and cellular responses to extracellular stimuli, making these cell lines invaluable for elucidating complex cellular mechanisms.
In terms of scientific importance, PLCE1 knockout models play a crucial role in advancing our understanding of pathophysiological conditions. Their applications span across molecular biology, pharmacology, and therapeutic development, with potential for drug discovery targeting PLCE1-related pathways or validating the efficacy of new pharmacological agents.
Compared to traditional methods that rely on transfection or chemical inhibition, the use of PLCE1 Gene Knockout Cell Lines presents distinct advantages. These include high specificity in targeting the PLCE1 gene, consistent knockout efficiency, and the ability to easily create stable cell lines for long-term experiments. Furthermore, researchers benefit from the clarity of results that typically arise in gene knockout settings.
For researchers and clinicians alike, the value of PLCE1 Gene Knockout Cell Lines lies in their ability to facilitate groundbreaking discoveries and advancements in personalized medicine. By understanding the intricacies of PLCE1-related cellular functions, users can better develop targeted therapies and improve patient outcomes.
Our company brings years of expertise in the field of gene editing and cellular biology, ensuring that our PLCE1 Gene Knockout Cell Lines meet the highest standards of scientific rigor and reproducibility. We are committed to supporting your research endeavors with top-tier biological products that drive innovation forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.